Ilevro (Nepafenac) Drug Interactions: 2 Major, 49 Moderate
Ilevro (Nepafenac) Drug Interactions
Check all documented drug-to-drug interactions. Major, moderate, and minor interactions with descriptions.
A therapy excluded from this list does not necessarily mean no interaction exists between that therapy and Ilevro. Always confirm against the full prescribing information.
63 interactions
Aceclofenac
The risk or severity of adverse effects can be increased when Aceclofenac is combined with Nepafenac.
Level 1 evidence
Acetylsalicylic acid
The therapeutic efficacy of Acetylsalicylic acid can be decreased when used in combination with Nepafenac.
Level 1 evidence
Aminosalicylic acid
The therapeutic efficacy of Aminosalicylic acid can be decreased when used in combination with Nepafenac.
Level 1 evidence
Antipyrine
The risk or severity of adverse effects can be increased when Antipyrine is combined with Nepafenac.
Level 1 evidence
Balsalazide
The therapeutic efficacy of Balsalazide can be decreased when used in combination with Nepafenac.
Level 1 evidence
Bismuth subsalicylate
The therapeutic efficacy of Bismuth subsalicylate can be decreased when used in combination with Nepafenac.
Level 1 evidence
Bromfenac
The risk or severity of adverse effects can be increased when Bromfenac is combined with Nepafenac.
Level 1 evidence
Capecitabine
Capecitabine may increase the nephrotoxic activities of Nepafenac.
Level 1 evidence
Celecoxib
The risk or severity of adverse effects can be increased when Celecoxib is combined with Nepafenac.
Level 1 evidence
Choline salicylate
The therapeutic efficacy of Choline salicylate can be decreased when used in combination with Nepafenac.
Level 1 evidence
Diclofenac
The risk or severity of adverse effects can be increased when Diclofenac is combined with Nepafenac.
Level 1 evidence
Diflunisal
The therapeutic efficacy of Diflunisal can be decreased when used in combination with Nepafenac.
Level 1 evidence
Enter your NPI to unlock 2 major interactions for Ilevro
Ilevro (Nepafenac) has 63 documented drug interactions. Always review the full list with a pharmacist before co-prescribing.
Ilevro (Nepafenac) has 2 major, 49 moderate, and 12 minor documented interactions.
A therapy excluded from this list does not necessarily mean no interaction exists between that therapy and Ilevro. Always confirm against the full prescribing information.